Autoantibodies Against the Exocrine Pancreas in Autoimmune Pancreatitis: Gene and Protein Expression Profiling and Immunoassays Identify Pancreatic Enzymes as a Major Target of the Inflammatory ProcessAMERICAN JOURNAL OF GASTROENTEROLOGYIF7.62010-09-01120OAAI
Interdependence of Gemcitabine Treatment, Transporter Expression, and Resistance in Human Pancreatic Carcinoma CellsNEOPLASIAIF7.72010-09-01119OAAI
Evidence linking CD44-positive cells and gemcitabine resistance in pancreatic cancer cells: need for further substantiationINTERNATIONAL JOURNAL OF CANCERIF4.72010-04-210OAAI
Therapy with Cell Encapsulation for Substitution of Organ Function and Tumor TreatmentADVANCED ENGINEERING MATERIALSIF3.32009-08-214PREAI
Regulation and functional role of the Runt-related transcription factor-2 in pancreatic cancerBRITISH JOURNAL OF CANCERIF6.82007-09-1864OAAI
Genes and proteins differentially expressed during in vitro malignant transformation of bovine pancreatic duct cellsNEOPLASIAIF7.72007-02-013OAAI
Aberrant expression of a disintegrin and metalloproteinase 17/tumor necrosis factor-α converting enzyme increases the malignant potential in human pancreatic ductal adenocarcinomaCANCER RESEARCHIF16.62006-09-1868PREAI
Immortalized pancreatic duct cells in vitro and in vivoCELL AND MOLECULAR BIOLOGY OF PANCREATIC CARCINOMA: RECENT DEVELOPMENTS IN RESEARCH AND EXPERIMENTAL THERAPYIF02006-02-0617PREAI
Construction of recombinant retroviruses expressing mutated k-ras or mutated p53 genesCELL AND MOLECULAR BIOLOGY OF PANCREATIC CARCINOMA: RECENT DEVELOPMENTS IN RESEARCH AND EXPERIMENTAL THERAPYIF02006-02-060PREAI
Differentially expressed genes in normal and tumor pancreatic tissueCELL AND MOLECULAR BIOLOGY OF PANCREATIC CARCINOMA: RECENT DEVELOPMENTS IN RESEARCH AND EXPERIMENTAL THERAPYIF02006-02-063PREAI
Injection of encapsulated cells producing an ifosfamide-activating cytochrome P450 for targeted chemotherapy to pancreatic tumorsCELL AND MOLECULAR BIOLOGY OF PANCREATIC CARCINOMA: RECENT DEVELOPMENTS IN RESEARCH AND EXPERIMENTAL THERAPYIF02006-02-0631PREAI
Immortalization of pancreatic stellate cells as an in vitro model of pancreatic fibrosis:: deactivation is induced by matrigel and N-acetylcysteineLABORATORY INVESTIGATIONIF4.22005-10-01137PREAI
Peritoneal cancer treatment with CYP2B1 transfected, microencapsulated cells and ifosfamideCANCER GENE THERAPYIF52005-08-1219PREAI
Combined therapy of experimental pancreatic cancer with CYP2B1 producing cells:: low-dose ifosfamide and local tumor irradiationINTERNATIONAL JOURNAL OF CANCERIF4.72004-09-287PREAI
Expression of cancer testis antigens in pancreatic carcinoma cell lines, pancreatic adenocarcinoma and chronic pancreatitisINTERNATIONAL JOURNAL OF CANCERIF4.72004-01-2270OAAI
Gene expression profiles of microdissected pancreatic ductal adenocarcinomaVIRCHOWS ARCHIVIF3.12003-10-0198PRE
Immortalized bovine pancreatic duct cells become tumorigenic after transfection with mutant k-rasVIRCHOWS ARCHIVIF3.12001-03-0228PREAI
Transfection of a mutated ki-ras cDNA into SV40 immortalized pancreatic duct cells leads to malignant transformation.GASTROENTEROLOGYIF25.12000-04-010PREAI
Targeted chemotherapy with encapsulated, genetically modified cells engineered to produce CYP2B1, an ifosfamide converting enzyme.GASTROENTEROLOGYIF25.11998-04-010OAAI